Y, L., Q, Y., H, J., Y, Z., & X, S. (2025). GTV delineating for patients with postoperative glioma based on enhanced T2-FLAIR sequence instead of enhanced T1-TFE sequence: A feasibility study. Discover oncology, 16(1), 919. https://doi.org/10.1007/s12672-025-02697-8
Chicago Style (17th ed.) CitationY, Li, Yuan Q, Jiang H, Zhang Y, and Sun X. "GTV Delineating for Patients with Postoperative Glioma Based on Enhanced T2-FLAIR Sequence Instead of Enhanced T1-TFE Sequence: A Feasibility Study." Discover Oncology 16, no. 1 (2025): 919. https://doi.org/10.1007/s12672-025-02697-8.
MLA (9th ed.) CitationY, Li, et al. "GTV Delineating for Patients with Postoperative Glioma Based on Enhanced T2-FLAIR Sequence Instead of Enhanced T1-TFE Sequence: A Feasibility Study." Discover Oncology, vol. 16, no. 1, 2025, p. 919, https://doi.org/10.1007/s12672-025-02697-8.